Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Multiple Pulmonary Nodules: early-phase trial registry

1 of 5 indexed Multiple Pulmonary Nodules trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Multiple Pulmonary Nodules: 5 US clinical trials tracked, 1 recruiting.

Multiple Pulmonary Nodules is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Fresh Medical Laboratories, running 1 of these trials.

Enrollment posture brief

Registry condition multiple-pulmonary-nodules

OPEN 1 | RECR 20% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Multiple Pulmonary Nodul (th…20%
Open-enrollment share among volume-matched conditions near Multiple Pulmonary Nodules

Multiple Pulmonary Nodules lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Multiple Pulmonary Nodules on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Multiple Pulmonary Nodules is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Multiple Pulmonary Nodules research.

    Fresh Medical Laboratories accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Multiple Pulmonary Nodules enrolment sits around 420 participants.

    Median target enrolment is 420 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Multiple Pulmonary Nodules research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Multiple Pulmonary Nodules records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Positron Emission Tomography (PET/CT) Diagnostic test
1 trials
Fluorine F 18 L-glutamate Derivative BAY94-9392 Drug
1 trials
Computed Tomography Diagnostic test
1 trials
TeaM OUT Intervention Behavioral
1 trials
Fludeoxyglucose F-18 Drug
1 trials
Ion Endoluminal System Device
1 trials
Enhanced Usual Care Behavioral
1 trials

US sites by state

Facility locations filed on Multiple Pulmonary Nodules trials. A trial with sites in several states counts in each.

Texas 3 trials
South Carolina 3 trials
Minnesota 3 trials
Illinois 3 trials
California 3 trials
Wisconsin 2 trials
Utah 2 trials
New York 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Multiple Pulmonary Nodules page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Multiple Pulmonary Nodules condition card totals 5 registered trials; most-linked intervention Positron Emission Tomography (PET/CT); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.